pamidronate has been researched along with Synovioma in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tumor-induced hypercalcemia is a frequent complication of advanced cancers, but it has been rarely reported in patients with sarcoma." | 1.34 | Tumor induced hypercalcemia in a patient with mediastinal synovial sarcoma. ( Badiei, Z; Hiradfar, M; Vakili, R; Zabolinejad, N, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Osanai, T | 1 |
| Tsuchiya, T | 1 |
| Sugawara, M | 1 |
| Vakili, R | 1 |
| Hiradfar, M | 1 |
| Zabolinejad, N | 1 |
| Badiei, Z | 1 |
2 other studies available for pamidronate and Synovioma
| Article | Year |
|---|---|
Rapid pain relief and marked sclerotic change of multiple bone metastases from a synovial sarcoma after treatment with intravenous pamidronate and chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neopla | 2009 |
Tumor induced hypercalcemia in a patient with mediastinal synovial sarcoma.
Topics: Adolescent; Bone Density Conservation Agents; Diphosphonates; Humans; Hypercalcemia; Male; Mediastin | 2007 |